These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21542792)

  • 1. Comparison of QSARs and characterization of structural basis of bioactivity using partial order theory and formal concept analysis: a case study with mutagenicity.
    Restrepo G; Basak SC; Mills D
    Curr Comput Aided Drug Des; 2011 Jun; 7(2):109-21. PubMed ID: 21542792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenicity of the aromatic amines: from structure-activity relationships to mechanisms of action and risk assessment.
    Benigni R; Passerini L
    Mutat Res; 2002 Jul; 511(3):191-206. PubMed ID: 12088717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of mutagenicity of aromatic and heteroaromatic amines from structure: a hierarchical QSAR approach.
    Basak SC; Mills DR; Balaban AT; Gute BD
    J Chem Inf Comput Sci; 2001; 41(3):671-8. PubMed ID: 11410045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of aromatic amines mutagenicity from theoretical molecular descriptors.
    Gramatica P; Consonni V; Pavan M
    SAR QSAR Environ Res; 2003 Aug; 14(4):237-50. PubMed ID: 14506868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting genotoxicity of aromatic and heteroaromatic amines using electrotopological state indices.
    Cash GG; Anderson B; Mayo K; Bogaczyk S; Tunkel J
    Mutat Res; 2005 Aug; 585(1-2):170-83. PubMed ID: 15961341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A QSAR investigation of the role of hydrophobicity in regulating mutagenicity in the Ames test: 1. Mutagenicity of aromatic and heteroaromatic amines in Salmonella typhimurium TA98 and TA100.
    Debnath AK; Debnath G; Shusterman AJ; Hansch C
    Environ Mol Mutagen; 1992; 19(1):37-52. PubMed ID: 1732103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR Study for Carcinogenic Potency of Aromatic Amines Based on GEP and MLPs.
    Song F; Zhang A; Liang H; Cui L; Li W; Si H; Duan Y; Zhai H
    Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27854309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of mutagenicity of monocyclic aromatic amines: quantitative structure-activity relationships.
    Chung KT; Kirkovsky L; Kirkovsky A; Purcell WP
    Mutat Res; 1997 Aug; 387(1):1-16. PubMed ID: 9254889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Theoretical approaches to predicting the metabolism and toxicity of aromatic amines].
    Kharchevnikova NV; Zholdakova ZI; Zhurkov VS
    Gig Sanit; 1998; (4):62-5. PubMed ID: 9721509
    [No Abstract]   [Full Text] [Related]  

  • 10. Avoidance of the Ames test liability for aryl-amines via computation.
    McCarren P; Bebernitz GR; Gedeck P; Glowienke S; Grondine MS; Kirman LC; Klickstein J; Schuster HF; Whitehead L
    Bioorg Med Chem; 2011 May; 19(10):3173-82. PubMed ID: 21524589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Aromatic Amine Mutagenicity with Confidence: A Case Study Using Conformal Prediction.
    Norinder U; Myatt G; Ahlberg E
    Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30158463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explanation for main features of structure-genotoxicity relationships of aromatic amines by theoretical studies of their activation pathways in CYP1A2.
    Shamovsky I; Ripa L; Börjesson L; Mee C; Nordén B; Hansen P; Hasselgren C; O'Donovan M; Sjö P
    J Am Chem Soc; 2011 Oct; 133(40):16168-85. PubMed ID: 21894985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of QSARs in identification of mutagenicity mechanisms of nitro and amino aromatic compounds against Salmonella typhimurium species.
    Jillella GK; Khan K; Roy K
    Toxicol In Vitro; 2020 Jun; 65():104768. PubMed ID: 31926304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR models for discriminating between mutagenic and nonmutagenic aromatic and heteroaromatic amines.
    Benigni R; Passerini L; Gallo G; Giorgi F; Cotta-Ramusino M
    Environ Mol Mutagen; 1998; 32(1):75-83. PubMed ID: 9707101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of rodent carcinogenicity of aromatic amines: a quantitative structure-activity relationships model.
    Franke R; Gruska A; Giuliani A; Benigni R
    Carcinogenesis; 2001 Sep; 22(9):1561-71. PubMed ID: 11532881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic Reactivity Descriptors for the Prediction of Ames Mutagenicity of Primary Aromatic Amines.
    Kuhnke L; Ter Laak A; Göller AH
    J Chem Inf Model; 2019 Feb; 59(2):668-672. PubMed ID: 30694664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship investigation of the role of hydrophobicity in regulating mutagenicity in the Ames test: 2. Mutagenicity of aromatic and heteroaromatic nitro compounds in Salmonella Typhimurium TA100.
    Debnath AK; Lopez de Compadre RL; Shusterman AJ; Hansch C
    Environ Mol Mutagen; 1992; 19(1):53-70. PubMed ID: 1732104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens.
    Benigni R; Bossa C; Netzeva T; Rodomonte A; Tsakovska I
    Environ Mol Mutagen; 2007 Dec; 48(9):754-71. PubMed ID: 18008355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.
    Ahlberg E; Amberg A; Beilke LD; Bower D; Cross KP; Custer L; Ford KA; Van Gompel J; Harvey J; Honma M; Jolly R; Joossens E; Kemper RA; Kenyon M; Kruhlak N; Kuhnke L; Leavitt P; Naven R; Neilan C; Quigley DP; Shuey D; Spirkl HP; Stavitskaya L; Teasdale A; White A; Wichard J; Zwickl C; Myatt GJ
    Regul Toxicol Pharmacol; 2016 Jun; 77():1-12. PubMed ID: 26879463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR modelling for mutagenic potency of heteroaromatic amines by optimal SMILES-based descriptors.
    Toropov AA; Toropova AP; Benfenati E
    Chem Biol Drug Des; 2009 Mar; 73(3):301-12. PubMed ID: 19207466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.